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Background
Abuse of anabolic steroids to induce skeletal muscle
hypertrophy is widespread amongst recreational body-
builders, however, the cardiac effects of such drugs have
not been systematically documented. The ability of car-
diovascular magnetic resonance (CMR) to image the
myocardium in any plane and achieve full myocardial
coverage renders it the gold standard for assessing LV
volumes and mass.We sought to investigate the cardiac
effects of anabolic steroid use with CMR hypothesising
that significant hypertrophy and distinct LV remodelling
would be seen in steroid users relative to non-users.
Methods
A total of 23 recreational bodybuilders were studied - 15
anabolic steroid users and 8 non-users. CMR was
undertaken on a 1.5T Avanto (Siemens, Erlangen, Ger-
many) using breath-hold steady-state free precession
cine sequences. Three long-axis images were obtained
followed by sequential short axis cines from the AV-
groove to the apex. Late gadolinium enhancement
(LGE) imaging was performed ~10 min after intrave-
nous Gadovist 0.1 mmol/kg (Schering, Berlin, Germany).
Indexed LV and RV ventricular volumes, ejection frac-
tion and indexed LV mass were determined using a
semi-automated threshold-based algorithm after manual
tracing of epicardial and endocardial borders (CMRtools,
London, UK). LV remodelling index was calculated as
the ratio of LV-mass to LV end-diastolic volume (LV-
EDV).
Results
None of the subjects exhibited any late gadolinium
enhancement. Mean indexed LV and RV volumes and
EF were comparable for the two groups (Table 1). How-
ever, there was significant left ventricular hypertrophy
(LVH) in the steroid users with both increased indexed
LV mass and peak wall thickness relative to non-users
(Table 1). Peak wall thickness often exceeded the >15
mm cut off used to diagnose hypertrophic cardiomyopa-
thy (range 10-17 mm in steroid users versus 7-11 mm
in non-users). The LV remodelling index was signifi-
cantly higher in the steroid users versus the controls
(Table 1) implying increases in LV mass with relatively
preserved volumes in comparison to the more eccentric
LV remodelling seen in the non-users.
Conclusions
Anabolic steroid use amongst bodybuilders can induce
significant left ventricular hypertrophy. The pattern and
severity of remodelling can mimic hypertrophic cardio-
myopathy. The use of such drugs should be considered
in the differential diagnosis of significant otherwise
unexplained left ventricular hypertrophy, particularly in
the athletic cohort.
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Table 1
Anabolic Steroid Users (mean±SD, n=15) Non-users (mean±SD, n=8) P Value
Age (years) 30.1±4.92 28.8±6.15 0.61
Body Surface Area (m
2) 2.15±0.21 1.99±0.15 0.077
Indexed LV-EDV (g/m
2) 92.8±12.2 94.1±12.1 0.82
Indexed LV-ESV (g/m
2) 36.4±6.55 35.3±5.98 0.70
LV EF (%) 61.1±2.66 62.5±3.33 0.27
Indexed LV Mass (g/m
2) 96.3±13.9 82.4±15.0 0.037
Maximum Wall Thickness (mm) 12.9±2.2 9.38±1.3 <0.001
LV Remodeling Index (g/ml) 1.05±0.16 0.88±0.11 0.015
Indexed RV-EDV (g/m
2) 95.3±29.6 100±18.2 0.69
Indexed RV-ESV (g/m
2) 36.4±6.55 35.3±5.98 0.70
RV EF (%) 51.9±3.9 59.0±4.7 0.003
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